IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q2 2025 Holdings

Filed 2025-08-14 | 6 holdings | $176.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Immunome Inc(IMNM)COM45257U108$44.3M4,768,58325.1%
Sionna Therapeutics Inc(SION)COM829401108$43.0M2,478,03024.4%
Zenas Biopharma Inc(ZBIO)COM98937L105$36.4M3,761,35920.6%
Upstream BIO Inc(UPB)COM91678A107$27.0M2,459,70315.3%
Compass Therapeutics Inc(CMPX)COM20454B104$20.2M7,788,15011.5%
Camp4 Therapeutics Corp(CAMP)COM13463J101$5.5M3,785,8023.1%